Literature DB >> 28528567

Cognitive behavioral therapy positively affects fatigue in patients with multiple sclerosis: Results of a randomized controlled trial.

Lizanne E van den Akker1, Heleen Beckerman1, Emma H Collette2, Jos Wr Twisk3, Gijs Bleijenberg4, Joost Dekker5, Hans Knoop6, Vincent de Groot1.   

Abstract

BACKGROUND: Fatigue is a common symptom in multiple sclerosis (MS) and often restricts societal participation. Cognitive behavioral therapy (CBT) may alleviate MS-related fatigue, but evidence in literature is inconclusive.
OBJECTIVE: To evaluate the effectiveness of CBT to improve MS-related fatigue and participation.
METHODS: In a multi-center, assessor-masked, randomized controlled trial, participants with severe MS-related fatigue were assigned to CBT or control treatment. CBT consisted of 12 individual sessions with a psychologist trained in CBT, the control treatment consisted of three consultations with a MS nurse, both delivered over 16 weeks. Assessments were at baseline, 8, 16 (i.e. post-intervention), 26, and 52 weeks post-baseline. Primary outcomes were the Checklist Individual Strength-fatigue subscale (CIS20r fatigue) and the Impact on Participation and Autonomy questionnaire (IPA). Data were analyzed according to the intention-to-treat principle, using mixed-model analysis.
RESULTS: Between 2011 and 2014, 91 patients were randomized (CBT: n = 44; control: n = 47). Between-group analysis showed a positive post-intervention effect for CBT on CIS20r fatigue (T16: -6.7 (95% confidence interval (CI) = -10.7; -2.7) points) that diminished during follow-up (T52: 0.5 (95% CI = -3.6; 4.4)). No clinically relevant effects were found on societal participation.
CONCLUSION: Severe MS-related fatigue can be reduced effectively with CBT in the short term. More research is needed on how to maintain this effect over the long term.

Entities:  

Keywords:  MS nurse; Multiple sclerosis; cognitive behavior therapy; fatigue; participation; randomized controlled trial; rehabilitation medicine

Mesh:

Year:  2017        PMID: 28528567     DOI: 10.1177/1352458517709361

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  15 in total

1.  Are the effects of cognitive behavior therapy for severe fatigue in cancer survivors sustained up to 14 years after therapy?

Authors:  Lidewij D Van Gessel; Harriët J G Abrahams; Hetty Prinsen; Gijs Bleijenberg; Marianne Heins; Jos Twisk; Hanneke W M Van Laarhoven; Stans C A H H V M Verhagen; Marieke F M Gielissen; Hans Knoop
Journal:  J Cancer Surviv       Date:  2018-04-12       Impact factor: 4.442

2.  Medically unexplained symptoms: assessment and management.

Authors:  Mujtaba Husain; Trudie Chalder
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

3.  Evidence-Based Rehabilitation for Multiple Sclerosis Made Easy: The Online Applying Evidence with Confidence (APPECO) Platform.

Authors:  Martin Heine; Heleen Beckerman; Päivi Hämäläinen; Vincent de Groot
Journal:  Int J MS Care       Date:  2020-09-14

4.  Daily Temporal Associations Between Physical Activity and Symptoms in Multiple Sclerosis.

Authors:  Anna L Kratz; Nora E Fritz; Tiffany J Braley; Eric L Scott; Emily Foxen-Craft; Susan L Murphy
Journal:  Ann Behav Med       Date:  2019-01-01

Review 5.  Improving Outcomes in Pediatric Multiple Sclerosis: Current and Emerging Treatments.

Authors:  Colin Wilbur; E Ann Yeh
Journal:  Paediatr Drugs       Date:  2019-06       Impact factor: 3.930

6.  Effectiveness of Group Counseling with a Client-Centered Approach Based on the GATHER Principles on Sexual Satisfaction in Women with Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Shabnam Sazesh; Sara Esmaelzadeh Saeieh; Malihe Farid; Mansoureh Refaei; Mansoureh Yazdkhasti
Journal:  Iran J Med Sci       Date:  2021-03

7.  High prevalence of fatigue in contemporary patients with multiple sclerosis.

Authors:  Line Broch; Cecilia Smith Simonsen; Heidi Øyen Flemmen; Pål Berg-Hansen; Åshild Skardhamar; Heidi Ormstad; Elisabeth Gulowsen Celius
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-03-18

8.  Diurnal Cortisol Secretion Is Not Related to Multiple Sclerosis-Related Fatigue.

Authors:  Arjan Malekzadeh; Ilona Bader; Julia van Dieteren; Annemieke C Heijboer; Heleen Beckerman; Jos W R Twisk; Vincent de Groot; Charlotte E Teunissen
Journal:  Front Neurol       Date:  2020-01-28       Impact factor: 4.003

9.  Testing non-inferiority of blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis and the effectiveness of blended booster sessions aimed at improving long-term outcome following both therapies: study protocol for two observer-blinded randomized clinical trials.

Authors:  Marieke Houniet-de Gier; Heleen Beckerman; Kimberley van Vliet; Hans Knoop; Vincent de Groot
Journal:  Trials       Date:  2020-01-20       Impact factor: 2.279

10.  The 2-minute walk test is not a valid method to determine aerobic capacity in persons with Multiple Sclerosis.

Authors:  Heleen Beckerman; Martin Heine; Lizanne E van den Akker; Vincent de Groot
Journal:  NeuroRehabilitation       Date:  2019       Impact factor: 2.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.